UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Randomized phase II trial of cisplatin/gemcitabine with or without LY293111, a multiple eicosonaid pathway modulator, in patients with chemotherapy naïve advanced non-small cell lung carcinoma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7024-7024

2006

Volltextzugriff (PDF)

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2636-2644

2003

Volltextzugriff (PDF)

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2023-04, Vol.41 (12), p.2125-2133

2023

Volltextzugriff (PDF)

Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3016-3024

2003

Volltextzugriff (PDF)

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1545-1552

2007

Volltextzugriff (PDF)

Quantitative CT detects changes in airway dimensions and air-trapping after bronchial thermoplasty for severe asthma

European journal of radiology, 2018-10, Vol.107, p.33-38

2018

Volltextzugriff (PDF)

Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2800-2807

2006

Volltextzugriff (PDF)

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

British journal of cancer, 2008-05, Vol.98 (10), p.1608-1613

2008

Volltextzugriff (PDF)

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Blood, 2005-08, Vol.106 (3), p.1021-1030

2005

Volltextzugriff (PDF)

Endobronchial Ultrasound Elastography for Differentiating Benign and Malignant Lymph Nodes

Respiration, 2020-12, Vol.99 (9), p.779-783

2020

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2003-08, Vol.95 (15), p.1118-1127

2003

Volltextzugriff (PDF)

Bronchial thermoplasty: interventional therapy in asthma

Therapeutic Advances in Respiratory Disease, 2014-02, Vol.8 (1), p.22-29

2014

Volltextzugriff (PDF)

SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results

Annals of oncology, 2004-06, Vol.15 (6), p.906-914

2004

Volltextzugriff (PDF)

Total Pulmonary Vein Occlusion as a Consequence of Catheter Ablation for Atrial Fibrillation Mimicking Primary Lung Disease

Journal of cardiovascular electrophysiology, 2003-04, Vol.14 (4), p.366-370

2003

Volltextzugriff (PDF)

Phase II trial of ZD0473 as second-line therapy in mesothelioma

European journal of cancer (1990), 2002-12, Vol.38, p.S19-S24

2002

Volltextzugriff (PDF)

Instabilities and pattern formation during the self-organized growth of nanoparticles on graphite

Surface science, 2002, Vol.496 (1), p.L18-L22

2002

Volltextzugriff (PDF)

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life : A randomized controlled trial

Lung cancer (Amsterdam, Netherlands), 2006-08, Vol.53 (2), p.231-239

2006

Volltextzugriff (PDF)

Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial

Journal of thoracic oncology, 2007-03, Vol.2 (3), p.221-229

2007

Volltextzugriff (PDF)

Dyspnea in a 45-year-old man with liver cirrhosis

Deutsche medizinische Wochenschrift (1946), 2011-02, Vol.136 (6), p.258

2011

Volltextzugriff (PDF)

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: Quality of life and 6-years’-follow-up results from a randomised phase III trial

Lung cancer (Amsterdam, Netherlands), 2006-07, Vol.53 (1), p.67-75

2006

Volltextzugriff (PDF)

Ifosfamide, carboplatin and etoposide combined with 41.8 °C whole body hyperthermia for malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2003-03, Vol.39 (3), p.339-345

2003

Volltextzugriff (PDF)

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide—A phase II study

Lung cancer (Amsterdam, Netherlands), 2003, Vol.39 (1), p.63-69

2003

Volltextzugriff (PDF)

Effect of chemotherapy for advanced non-small cell lung cancer on patients’ quality of life

Lung cancer (Amsterdam, Netherlands), 2006-08, Vol.53 (2), p.231-239

2006

Volltextzugriff (PDF)

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7010-7010

2004

Volltextzugriff (PDF)

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7010-7010

2004

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(45)
Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Female
(33)
Male
(29)
Middle Aged
(29)
Adult
(24)
Aged
(23)
Oncology
(20)
Lung Neoplasms - Drug Therapy
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Animals
(13)
Chemotherapy
(13)
Cyclic Amp - Metabolism
(13)
Respiratory System
(13)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(12)
Antineoplastic Agents
(11)
Pharmacology. Drug Treatments
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized phase II trial of cisplatin/gemcitabine with or without LY293111, a multiple eicosonaid pathway modulator, in patients with chemotherapy naïve advanced non-small cell lung carcinoma

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

Quantitative CT detects changes in airway dimensions and air-trapping after bronchial thermoplasty for severe asthma

Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

Endobronchial Ultrasound Elastography for Differentiating Benign and Malignant Lymph Nodes

Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer

Bronchial thermoplasty: interventional therapy in asthma

SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results

Total Pulmonary Vein Occlusion as a Consequence of Catheter Ablation for Atrial Fibrillation Mimicking Primary Lung Disease

Phase II trial of ZD0473 as second-line therapy in mesothelioma

Instabilities and pattern formation during the self-organized growth of nanoparticles on graphite

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life : A randomized controlled trial

Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial

Dyspnea in a 45-year-old man with liver cirrhosis

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: Quality of life and 6-years’-follow-up results from a randomised phase III trial

Ifosfamide, carboplatin and etoposide combined with 41.8 °C whole body hyperthermia for malignant pleural mesothelioma

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide—A phase II study

Effect of chemotherapy for advanced non-small cell lung cancer on patients’ quality of life

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

Suchergebnisse filtern